Triple

T22651384
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EC) No 1394/2007 E559101 entity
Predicate complements P162 FINISHED
Object Regulation (EC) No 726/2004 laying down Community procedures for the authorization and supervision of medicinal products — NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Regulation (EC) No 726/2004 laying down Community procedures for the authorization and supervision of medicinal products | Statement: [Regulation (EC) No 1394/2007, complements, Regulation (EC) No 726/2004 laying down Community procedures for the authorization and supervision of medicinal products]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Regulation (EC) No 726/2004 laying down Community procedures for the authorization and supervision of medicinal products
Context triple: [Regulation (EC) No 1394/2007, complements, Regulation (EC) No 726/2004 laying down Community procedures for the authorization and supervision of medicinal products]
  • A. Regulation (EC) No 726/2004 chosen
    Regulation (EC) No 726/2004 is an EU law that establishes the centralized procedure for the authorization and supervision of medicinal products and defines the role and powers of the European Medicines Agency.
  • B. Directive 2001/82/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products
    Directive 2001/82/EC is a key piece of European Union legislation that harmonizes the rules for the authorization, manufacture, distribution, and pharmacovigilance of veterinary medicinal products across EU member states.
  • C. Regulation (EC) No 141/2000 on orphan medicinal products
    Regulation (EC) No 141/2000 on orphan medicinal products is a key European Union law that establishes incentives and a special approval framework to encourage the development and marketing of medicines for rare diseases.
  • D. Council Regulation (EC) No 510/2006
    Council Regulation (EC) No 510/2006 was an EU law establishing the system for protecting geographical indications and designations of origin for agricultural products and foodstuffs before being replaced by Regulation (EU) No 1151/2012.
  • E. Regulation (EC) No 1901/2006
    Regulation (EC) No 1901/2006 is the European Union’s Paediatric Regulation, establishing rules to ensure that medicines for children are researched, developed, and authorized to the same high standards as those for adults.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e245489dd88190b1f674acf61c8769 completed April 17, 2026, 2:35 p.m.
NER Named-entity recognition batch_69f1703c5538819089d9b5349f26ea6d completed April 29, 2026, 2:43 a.m.
Created at: April 17, 2026, 3:06 p.m.